Physician profile
Michael A Curi
NPI 1033222161
$32,310.67
in general payments reported to CMS, 2019-2025
23 companies · $24K in 2025
The $24K reported for 2025 was more than what 95% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $896 · 2020: $60.38 · 2021: $1,088 · 2022: $432 · 2023: $1,475 · 2024: $4,091 · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Food and Beverage: $4,388 · Travel and Lodging: $2,720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,725.00 |
| Food and Beverage | $4,388.26 |
| Travel and Lodging | $2,720.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Humacyte Global, INC. | $22,673.67 | 2025 | Symvess |
| Advanced Oxygen Therapy INC. | $2,946.15 | 2023-2024 | Topical Oxygen Chamber For Extremities |
| Cook Medical LLC | $1,797.11 | 2019-2025 | Cook, Zenith Alpha, Zenith Spiral-Z |
| W. L. Gore & Associates, INC. | $1,226.09 | 2019-2025 | Gore Tag Thoracic Endoprosthesis, Gore Viabahn Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo |
| Silk Road Medical, INC. | $891.58 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Boston Scientific Corporation | $599.19 | 2022-2025 | General - Non-Vascular Intervention, Angiojet Ultra 5000a |
| Medtronic, INC. | $552.14 | 2021-2024 | Endurant Iis, Ellipsys Vascular Access System |
| Endologix LLC | $447.57 | 2025 | Endocross Device, Torus Stent Graft System |
| Bolton Medical INC | $388.36 | 2023-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System |
| Medtronic Vascular, INC. | $203.00 | 2019 | |
| Kerecis Limited | $133.91 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Cardiovascular Systems INC. | $117.93 | 2021 | |
| Inari Medical, INC. | $67.28 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $57.07 | 2021-2024 | Jeti Peripheral Catheter |
| Bard Peripheral Vascular, INC. | $39.57 | 2020-2025 | Venclose Maven Catheter |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $34.32 | 2024 | Activ.A.C. |
| Shockwave Medical, INC | $33.95 | 2025 | |
| Baxter Healthcare | $21.23 | 2019 | |
| Lemaitre Vascular, INC. | $19.57 | 2025 | Restoreflow |
| Acera Surgical, INC. | $18.06 | 2025 | Restrata Wound Matrix |
| Cordis US Corp. | $16.29 | 2024 | Mynx Control |
| Cashflow Solutions, LLC | $13.52 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Smith+Nephew, INC. | $13.11 | 2024 | Collagenase Santyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Curi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.